Fei Chen - Profile and Investment Details

Investor Profile

Fei Chen is a Venture Capital based in Shanghai, China with a diverse investment portfolio that includes companies such as KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical, Metacrine, ImmuneOnco Biopharma, Targeting One, Alector, Hangzhou Just Biotherapeutics (Just China), Fortis Therapeutics, Harpoon Therapeutics, Legend Biotech, Elpiscience Biopharmaceuticals, Ansun BioPharma, Geneseeq, Turning Point TherapeuticsReadCoor, dMed, Singlera Genomics, Singleron Biotechnologies, IMPACT Therapeutics, Nucleix, Geneception, NuVera Medical, CARsgen Therapeutics, Just - Evotec Biologics, Terns Pharmaceuticals, Tmunity Therapeutics, 360 Health, Transcenta, NextCure, Nuohui Health, Regor Therapeutics, InventisBio, EdiGene, Tempest Therapeutics, Gracell Biotechnologies, Sonoma BioTherapeutics, NiKang Therapeutics, Inhibrx, Rongchang Pharmaceutical, Remegen, Mailing Yiliao, Magnolia NeuroSciences, Burning Rock Biotech, Passage Bio, Fountain Medical Development, CanSinoBIO, MabSpace Biosciences, Sansure Biotech, NovoCodex, Gritstone Oncology, Veritas Genetics, ACEA BIO, Peijia Medical, Insilico Medicine, Jacobio Pharmaceuticals, Avedro, 360 Haoyao, Dizal Pharma, Connect Biopharmaceuticals, Qihan Biotech, Ionova Life Science, . Over time, Fei Chen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Fei Chen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Women Founded, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Medical Technologies, Robotics, Information Technology (IT), Venture Fundraising, Finance, Manufacturing, Biotechnology, Medical Devices, Genomics, Clinical Trials, Gene Therapy, Medical Diagnostics, Health Diagnostics, Market Intelligence, Renewable Energy, Medical, B2B, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Fei Chen, as their portfolio suggests a familiarity and interest in this area.

Understanding Fei Chen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.